Harry Fuentes | Head and Neck Oncology | Best Researcher Award

Dr. Mayo Clinic, United States

This detailed academic and professional record belongs to Dr. Harry Eduardo Fuentes Bayne, MD, MS. He is an Assistant Professor of Oncology and Assistant Professor of Medicine at the Mayo Clinic College of Medicine and Science, with current positions as a Consultant in the Division of Medical Oncology, Department of Oncology at Mayo Clinic, Rochester, Minnesota.

 

Professional Profiles:

Education:

Doctor of Medicine Universidad de Guayaquil, Guayaquil, Ecuador 05/02/2005 – 09/13/2011Residency, Internal Medicine John H. Stroger Jr, Hospital of Cook County, Chicago, Illinois 07/01/2014 – 06/30/2017Masters of Clinical Research Rush University, Chicago, Illinois 05/13/2015 – 05/13/2017Chief Resident John H. Stroger Jr, Hospital of Cook County, Chicago, Illinois 07/01/2017 – 06/30/2018Fellow, Hematology/Oncology Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minnesota 07/01/2018 – 06/30/2021Chief Fellow Mayo Clinic Division of Hematology/Oncology Fellowship, Rochester, Minnesota 06/01/2020 – 06/01/2021

Honors and Awards:

Mencion de HonorEscuela de Medicina de la Universidad de Guayaquil Annual Academic Achievement award received each year of Medical School (7 years)
06/01/2005 – 09/01/2011Premio Contenta Escuela de Medicina de la Universidad de Guayaquil Highest academic performance recognition given to a Medical Graduate.
09/01/2011 – PresentPremio Unico Ministry of Public Health of Ecuador Awarded by the National Institute of Hygiene and Tropical Medicine 11/15/2011 – Present

Strengths for the Award

  1. Educational Background and Training: Dr. Fuentes-Bayne has a robust educational and training background, including:
    • A Doctor of Medicine from Universidad de Guayaquil.
    • Residency in Internal Medicine at John H. Stroger Jr. Hospital of Cook County.
    • A Master’s in Clinical Research from Rush University.
    • Fellowship and Chief Fellowship in Hematology/Oncology at Mayo Clinic.
  2. Honors and Awards: He has received multiple prestigious awards, including:
    • Mencion de Honor from Escuela de Medicina de la Universidad de Guayaquil.
    • Premio Contenta, recognizing highest academic performance.
    • Premio Unico from the Ministry of Public Health of Ecuador.
  3. Leadership and Expertise: His role as Chief Resident and Chief Fellow indicates strong leadership skills and advanced expertise in his field. His extensive training in Hematology/Oncology is particularly noteworthy.
  4. Institutional Affiliation: Being affiliated with Mayo Clinic, a leading institution, adds credibility and indicates a high level of expertise and access to cutting-edge research and clinical resources.

Areas for Improvement

  1. Publication Record: While the provided highlights his educational and award history, details on his publication record, research contributions, or specific projects in hematology/oncology would be beneficial. A strong publication record in high-impact journals is often a key criterion for research awards.
  2. Research Impact: Information on the impact of his research, such as citation counts, novel contributions to the field, or involvement in significant research projects, would provide a clearer picture of his influence in the field.
  3. Continued Professional Development: Details on ongoing research activities, involvement in conferences, or contributions to professional societies would enhance the understanding of his current research engagement and professional growth.

 

✍️Publications Top Note :

Comparative effectiveness of anticoagulants in patients with cancer-associated thrombosis

Authors: IB Riaz, H Fuentes, Y Deng, SAA Naqvi, X Yao, LR Sangaralingham, …

Journal: JAMA Network Open

Volume/Issue: 6 (7), e2325283-e2325283

Citations: 11

Year: 2023

Risk assessment as a guide for the prevention of cancer-associated thromboembolism

Authors: A Al-Ogaili, HE Fuentes, AJ Tafur, J Caprini

Journal: International Angiology

Volume/Issue: Not specified

Citations: 9

Year: 2018

Primary liver diffuse large B-cell lymphoma following complete response for hepatitis C infection after direct antiviral therapy

Authors: XA Andrade, LH Paz, DM Oramas, HE Fuentes, P Kovarik, S Mishra, …

Journal: Acta Haematologica

Volume/Issue: 139 (2), 77-80

Citations: 9

Year: 2018

Predictors of active cancer thromboembolic outcomes: mortality associated with calf deep vein thrombosis

Authors: JPS Adum, LD Quintero, HE Fuentes, BB Lind, JA Caprini, AJ Tafur

Journal: International Angiology

Volume/Issue: Not specified

Citations: 9

Year: 2017

Conclusion

Dr. Harry Fuentes-Bayne demonstrates significant strengths in his educational background, leadership roles, and receipt of prestigious awards, which collectively position him as a strong candidate for a Research Award. To strengthen his candidacy further, providing detailed information about his research contributions, publication record, and ongoing projects would be advantageous. His strong academic and clinical background, coupled with notable awards, makes him a compelling candidate for recognition in the research community.

Prof Dr. Catherine Alix-Panabieres | Biopsie Liquide | Excellence in Research

Prof Dr. Catherine Alix-Panabieres | Biopsie Liquide | Excellence in Research

Prof Dr. Catherine Alix-Panabieres , CHU de Montpellier, France

Prof Dr. Catherine Alix-Panabieres is academic and researcher in the field of renewable energy, holds a PhD in Bio systems Engineering from Kangwon National University, South Korea. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Profiles:

Orcid

Google scholar

Position 🏥

Discipline: OncologyFunction: Professeur des Universités – Praticien Hospitalier (PU-PH); Full ProfessorLaboratory: Director of the Laboratory of Detection of Rare Circulating Human – LCCRH, Department of Pathology and Onco-Biology, University Medical Center of Montpellier – IURC, 641, avenue du Doyen Gaston Giraud, 34093 Montpellier Cedex 5 & CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.Phone: +33 4 11 75 99 31 / +33 6 88 80 06 74 (Mobile)Fax: +33 4 67 33 52 81

Academic Qualifications 🎓

2023: University Diploma in Medical Education and Communication2012: Habilitation (University of Montpellier, France)1995/98: PhD obtained on 25th November 1998 (University Louis Pasteur Strasbourg, France)1994/95: Master 2 in Molecular and Cellular Biology (Prof Jules Hoffmann, Nobel prize – ULP Strasbourg, France)

Professional Career Development 🚀

2023-24: Full Professor at the University of Montpellier2010-23: Maître de Conférences – Praticien Hospitalier (UMC and University of Montpellier)1999-2009: Post-doctorant (2 years) then researcher (9 years) at the UMC of Montpellier2022-2026: Visiting Professor at the University of Hamburg, Germany2021-24: Top 25 best researchers at the CHU of Montpellier2020-24: Work-package leader of the European Liquid Biopsy Society (ELBS)2020-23: Consultant for Menarini as an expert in the liquid biopsy field

Key Achievements and Honors 🏆

2016: Active Member of the European Society of Medical Oncology (ESMO)2013-18: Active Member of Pilot committee of the Pole of Cancer Research ‘SIRIC’ – Colon cancer axis2013: Creation and President of the Association « BIODETECT »2006 & 2002: Patents for innovative cancer detection technologies2021: International Liquid Biopsy Society (ISLB) Award for Lifetime Achievement2022: Prestigious Alexandr Savchuk Award

Key Publications 📚

h-index: 58i10-index: 113Citations: 16,738Notable Publications:”Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.” Br J Cancer. 2023″Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.” J Clin Oncol. 2023″Liquid Biopsy: From Discovery to Clinical Application.” Cancer Discovery 2021

Teaching Activity 🎓

Experience: Over 15 years of teaching in Oncology at the Faculties of Medicine and Sciences, University of MontpellierInternational Teaching: Bari (Italy), Beirut (Lebanon), Zürich (Switzerland), Aarhus (Denmark)Supervision: 20 theses, 9 Master 2, and 10 Master 1 students since 2016Publications: 14 education book chapters and reviews

Short Biography

Professor Catherine Alix-Panabières earned her PhD in 1998 from the University Louis Pasteur in Strasbourg, France. She has made significant strides in the field of oncology, particularly in the optimization of techniques for detecting and characterizing viable circulating tumor cells (CTCs). Notably, she co-coined the term ‘Liquid Biopsy’ and has received numerous awards for her contributions to cancer research. As the director of the Laboratory of Rare Human Circulating Cells (LCCRH), she continues to advance the field with innovative research and international collaborations.Her notable achievements include patents for cancer detection technologies, recognition from prestigious institutions such as the French Academy of Medicine, and significant contributions to the global understanding and application of liquid biopsy techniques in cancer research. Her work has been widely published and cited, reflecting her impact on the field of oncology.

📖 Publications Top Note :

Surfaceome: a new era in the discovery of immune evasion mechanisms of circulating tumor cells

Demographic Analysis of Cancer Research Priorities and Treatment Correlations

Aligning Cancer Research Priorities in Europe with Recommendations for Conquering Cancer: A Comprehensive Analysis